These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 8178384)

  • 1. Kidney Function After the First Kidney Stone Event.
    Haley WE; Enders FT; Vaughan LE; Mehta RA; Thoman ME; Vrtiska TJ; Krambeck AE; Lieske JC; Rule AD
    Mayo Clin Proc; 2016 Dec; 91(12):1744-1752. PubMed ID: 27776839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Water Loading and Uromodulin Secretion in Healthy Individuals and Idiopathic Calcium Stone Formers.
    LaFavers KA; Gaddy AR; Micanovic R; Lingeman J; Williams JC; Coe FL; El-Achkar TM; Worcester E
    Clin J Am Soc Nephrol; 2023 Aug; 18(8):1059-1067. PubMed ID: 37256909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of rare allelic variation in candidate genes among individuals with low and high urinary calcium excretion.
    Toka HR; Genovese G; Mount DB; Pollak MR; Curhan GC
    PLoS One; 2013; 8(8):e71885. PubMed ID: 23991001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Optimal Length of Pharmacological Prophylaxis in Calcium Kidney Stone Formers.
    Lombardi G; Ferraro PM; Gambaro G
    Kidney360; 2023 Sep; 4(9):e1318-e1321. PubMed ID: 37424064
    [No Abstract]   [Full Text] [Related]  

  • 5. The Conundrum of Alkali Therapy in Calcium Phosphate Stone Formers.
    Yau AA
    Kidney Int Rep; 2024 Mar; 9(3):721-724. PubMed ID: 38481489
    [No Abstract]   [Full Text] [Related]  

  • 6. Author Correction: Increased risk of chronic kidney disease in uric acid stone formers with high neutrophil-to-lymphocyte ratio.
    Tung HT; Liu CM; Huang HS; Lu ZH; Liu CJ
    Sci Rep; 2024 Jan; 14(1):2096. PubMed ID: 38267570
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormone replacement therapy and postmenopausal stone-formers.
    Assimos DG
    Rev Urol; 2003; 5(2):130. PubMed ID: 16985631
    [No Abstract]   [Full Text] [Related]  

  • 8. Familial forms of hypercalciuria.
    Favus MJ
    J Urol; 1989 Mar; 141(3 Pt 2):719-22. PubMed ID: 2645430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of urinary calcium excretion after oral calcium load in stone formers, their spouses and first-degree blood relatives.
    Kaul P; Sidhu H; Vaidyanathan S; Thind SK; Nath R
    Urol Int; 1994; 52(2):93-7. PubMed ID: 8178384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic predisposition to renal stone disease in the first-degree relatives of stone-formers.
    Marya RK; Dadoo RC; Sharma NK
    Urol Int; 1981; 36(4):245-7. PubMed ID: 7331055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological studies in hypercalciuric and normocalciuric stone formers.
    Minisola S; Scarda A; Medori C; Valtorta C; Antonelli R; Tabolli S; Rossi W; Mazzuoli G
    Urol Int; 1985; 40(2):65-71. PubMed ID: 3992738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acute acid loading on acid-base and calcium metabolism.
    Osther PJ
    Scand J Urol Nephrol; 2006; 40(1):35-44. PubMed ID: 16452054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.